Literature DB >> 7527616

Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non-transformed rat vascular smooth muscle cells.

D Leszczynski1, Y Zhao, M Luokkamäki, M L Foegh.   

Abstract

We examined the effect of several inhibitors/activators of various protein kinases on the proliferation and apoptosis of nontransformed rat coronary vascular smooth muscle cells (SMC). As expected, all the compounds (calphostin C, KT5720, KT5823, verapamil, W7, and dibutyryl-cAMP) inhibited SMC proliferation, as judged by [3H]thymidine incorporation. Three (calphostin C, verapamil and dibutyryl-cAMP) of the six compounds caused occurrence of the classical apoptotic morphology in SMC. The effect of calphostin C, an inhibitor of protein kinase C, was examined in more detail due to the known involvement of this kinase in regulation of apoptosis in a variety of cell types. In SMC cultures exposed for 1, 2, and 3 days to 0.1 mumol/L calphostin C, 7 +/- 1%, 32 +/- 3%, and 29 +/- 3% of cells underwent apoptosis, respectively, as assessed by cell morphology (control cultures had 1 to 3% of apoptotic cells). The effect of calphostin C was transient in that on day 6 following exposure to this compound the number of apoptotic cells declined to control values. Simultaneous with the induction of apoptotic morphology in SMC, a decline was seen (within 24 hours) in expression of the oncoprotein Bcl-2 in morphologically nonapoptotic SMC. An altered distribution of Bcl-2 was seen in the apoptotic cells. The calphostin C-induced generation of apoptotic cells in SMC cultures and the decline/alteration of Bcl-2 expression were not accompanied by degradation of DNA into nucleosomal fragments. In conclusion, normal, nontransformed rat coronary artery vascular SMC undergo apoptosis when exposed to an inhibitor of protein kinase C (calphostin C), to a calcium channel blocker (verapamil), and to a stimulator of cAMP-dependent protein kinase (dibutyryl-cAMP). The induction of apoptosis by the inhibitor of protein kinase C is accompanied by alterations in the Bcl-2 expression but not by DNA fragmentation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527616      PMCID: PMC1887488     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  A simple and rapid method for detection of apoptosis in human cells.

Authors:  F Rösl
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

Review 2.  Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C.

Authors:  Y Nishizuka
Journal:  Science       Date:  1992-10-23       Impact factor: 47.728

Review 3.  Cellular signalling in programmed cell death (apoptosis).

Authors:  D J McConkey; S Orrenius; M Jondal
Journal:  Immunol Today       Date:  1990-04

4.  K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases.

Authors:  H Kase; K Iwahashi; S Nakanishi; Y Matsuda; K Yamada; M Takahashi; C Murakata; A Sato; M Kaneko
Journal:  Biochem Biophys Res Commun       Date:  1987-01-30       Impact factor: 3.575

5.  Rat heart-derived endothelial and smooth muscle cell cultures: isolation, cloning and characterization.

Authors:  C A Diglio; P Grammas; F Giacomelli; J Wiener
Journal:  Tissue Cell       Date:  1988       Impact factor: 2.466

6.  The preparation of acylated derivatives of cyclic nucleotides.

Authors:  T Posternak; G Weimann
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

7.  Effects of N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide and other calmodulin antagonists (calmodulin interacting agents) on calcium-induced contraction of rabbit aortic strips.

Authors:  M Kanamori; M Naka; M Asano; H Hidaka
Journal:  J Pharmacol Exp Ther       Date:  1981-05       Impact factor: 4.030

8.  Calphostins (UCN-1028), novel and specific inhibitors of protein kinase C. I. Fermentation, isolation, physico-chemical properties and biological activities.

Authors:  E Kobayashi; K Ando; H Nakano; T Iida; H Ohno; M Morimoto; T Tamaoki
Journal:  J Antibiot (Tokyo)       Date:  1989-10       Impact factor: 2.649

9.  Multiple kinase arrest points in the G1 phase of nontransformed mammalian cells are absent in transformed cells.

Authors:  D M Gadbois; H A Crissman; R A Tobey; E M Bradbury
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

10.  Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis.

Authors:  M R Bennett; G I Evan; A C Newby
Journal:  Circ Res       Date:  1994-03       Impact factor: 17.367

View more
  11 in total

Review 1.  Molecular link between cholesterol, cytokines and atherosclerosis.

Authors:  D Kaul
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis.

Authors:  S Oliverio; A Amendola; F Di Sano; M G Farrace; L Fesus; Z Nemes; L Piredda; A Spinedi; M Piacentini
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

Review 3.  Can calcium antagonists provide a neuroprotective effect in Parkinson's disease?

Authors:  R L Rodnitzky
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

Review 4.  Apoptosis in the vasculature: mechanisms and functional importance.

Authors:  Z Mallat; A Tedgui
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

5.  Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability.

Authors:  S Björkerud; B Björkerud
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

6.  Cardiovascular medication use and risk for colorectal cancer.

Authors:  Denise M Boudreau; Elizabeth Koehler; Stephen J Rulyak; Sebastien Haneuse; Robert Harrison; Margaret T Mandelson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10-28       Impact factor: 4.254

7.  Tolerance induction ameliorates allograft vasculopathy in rat aortic transplants. Influence of Fas-mediated apoptosis.

Authors:  L M Akyürek; C Johnsson; D Lange; P Georgii-Hemming; E Larsson; B C Fellström; K Funa; G Tufveson
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

8.  The effect of calcium channel blockers on the outcome of acute myeloid leukemia.

Authors:  Young Kwang Chae; Anastasios Dimou; Sherry Pierce; Hagop Kantarjian; Michael Andreeff
Journal:  Leuk Lymphoma       Date:  2014-04-29

9.  Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme.

Authors:  Y J Geng; P Libby
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

10.  Long-term use of calcium channel blocking drugs and breast cancer risk in a prospective cohort of US and Puerto Rican women.

Authors:  Lauren E Wilson; Aimee A D'Aloisio; Dale P Sandler; Jack A Taylor
Journal:  Breast Cancer Res       Date:  2016-07-05       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.